High membrane protein oxidation in the human cerebral cortex

Redox Biology

Volumn 4, Issue , 2015, Pages 200-207

  Granold, Matthias ^a   Moosmann, Bernd ^a   Staib Lasarzik, Irina ^a   Arendt, Thomas ^b   del Rey, Adriana ^c   Engelhard, Kristin ^a   Behl, Christian ^a   Hajieva, Parvana ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Aging; Alzheimer's disease; Animal models; Neurodegeneration; Oxidative stress; Protein oxidation

Indexed keywords

CYTOPLASM PROTEIN; MEMBRANE PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOOXIDATION; BRAIN CORTEX; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; JUVENILE ANIMAL; LIPID PEROXIDATION; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PROTEIN CARBONYLATION; PROTEIN METABOLISM; PROTEIN OXIDATION; RAT; VERY ELDERLY; AGING; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOPLASM; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; SPECIES DIFFERENCE;

ANIMALIA; MAMMALIA; MURINAE; MUS; RATTUS; RODENTIA;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN ISCHEMIA; CEREBELLUM; CEREBRAL CORTEX; CYTOPLASM; FEMALE; HIPPOCAMPUS; HUMANS; LIPID PEROXIDATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEURONS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; SPECIES SPECIFICITY;

EID: 84921455837     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.12.013     Document Type: Article

References (43)

1. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. Journal of Neurochemistry 2006, 97(6):1634-1658. http://www.ncbi.nlm.nih.gov/pubmed/16805774, 10.1111/j.1471-4159.2006.03907.x.
2. Sayre L.M., Perry G., Smith M.A. Oxidative stress and neurotoxicity. Chemical Research in Toxicology 2008, 21(1):172-188. http://www.ncbi.nlm.nih.gov/pubmed/18052107, 10.1021/tx700210j.
3. Sohal R.S., Orr W.C. The redox stress hypothesis of aging. Free Radical Biology and Medicine 2012, 52(3):539-555. http://www.ncbi.nlm.nih.gov/pubmed/22080087, 10.1016/j.freeradbiomed.2011.10.445.
4. Höhn A., König J., Grune T. Protein oxidation in aging and the removal of oxidized proteins. Journal of Proteomics 2013, 92:132-159. http://www.ncbi.nlm.nih.gov/pubmed/23333925, 10.1016/j.jprot.2013.01.004.
5. Moosmann B., Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opinion on Investigational Drugs 2002, 11(10):1407-1435. http://www.ncbi.nlm.nih.gov/pubmed/12387703, 10.1517/13543784.11.10.1407.
6. Martínez A., Portero-Otin M., Pamplona R., Ferrer I. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathology 2010, 20(2):281-297. http://www.ncbi.nlm.nih.gov/pubmed/19725834, 10.1111/j.1750-3639.2009.00326.x.
7. Hensley K., Maidt M.L., Yu Z., Sang H., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. Journal of Neuroscience 1998, 18(20):8126-8132. http://www.ncbi.nlm.nih.gov/pubmed/9763459.
8. Pamplona R., Dalfó E., Ayala V., et al. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. Journal of Biological Chemistry 2005, 280(22):21522-21530. http://www.ncbi.nlm.nih.gov/pubmed/15799962, 10.1074/jbc.M502255200.
9. Hensley K., Hall N., Subramaniam R., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. Journal of Neurochemistry 1995, 65(5):2146-2156. http://www.ncbi.nlm.nih.gov/pubmed/7595501.
10. Lyras L., Cairns N.J., Jenner A., Jenner P., Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. Journal of Neurochemistry 1997, 68(5):2061-2069. http://www.ncbi.nlm.nih.gov/pubmed/9109533.
11. Nunomura A., Perry G., Pappolla M.A., et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. Journal of Neuroscience 1999, 19(6):1959-1964. http://www.ncbi.nlm.nih.gov/pubmed/10066249.
12. Wang J., Xiong S., Xie C., Markesbery W.R., Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. Journal of Neurochemistry 2005, 93(4):953-962. http://www.ncbi.nlm.nih.gov/pubmed/15857398, 10.1111/j.1471-4159.2005.03053.x.
13. Bender A., Hajieva P., Moosmann B. Adaptive antioxidant methionine accumulation in respiratory chain complexes explains the use of a deviant genetic code in mitochondria. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(43):16496-16501. http://www.ncbi.nlm.nih.gov/pubmed/18946048, 10.1073/pnas.0802779105.
14. Moosmann B., Behl C. Mitochondrially encoded cysteine predicts animal lifespan. Aging Cell 2008, 7(1):32-46. http://www.ncbi.nlm.nih.gov/pubmed/18028257, 10.1111/j.1474-9726.2007.00349.x.
15. Schindeldecker M., Stark M., Behl C., Moosmann B. Differential cysteine depletion in respiratory chain complexes enables the distinction of longevity from aerobicity. Mechanisms of Ageing and Development 2011, 132(4):171-179. http://www.ncbi.nlm.nih.gov/pubmed/21453719, 10.1016/j.mad.2011.03.002.
16. Butterfield D.A., Howard B.J., Yatin S., Allen K.L., Carney J.M. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(2):674-678. http://www.ncbi.nlm.nih.gov/pubmed/9012843, 10.1073/pnas.94.2.674.
17. Bisby R.H., Ahmed S., Cundall R.B. Repair of amino acid radicals by a vitamin E analogue. Biochemical and Biophysical Research Communications 1984, 119(1):245-251. http://www.ncbi.nlm.nih.gov/pubmed/6704121, 10.1016/0006-291X(84)91644-9.
18. Moosmann B., Behl C. Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins. European Journal of Biochemistry 2000, 267(18):5687-5692. http://www.ncbi.nlm.nih.gov/pubmed/10971578, 10.1046/j.1432-1327.2000.01658.x.
19. Hajieva P., Bayatti N., Granold M., Behl C., Moosmann B. Membrane protein oxidation determines neuronal degeneration. Journal of Neurochemistry 2015, Pubmed: 25393523. 10.1111/jnc.12987.
20. Moosmann B., Skutella T., Beyer K., Behl C. Protective activity of aromatic amines and imines against oxidative nerve cell death. Biological Chemistry 2001, 382(11):1601-1612. http://www.ncbi.nlm.nih.gov/pubmed/11767950, 10.1515/BC.2001.195.
21. Chang H.J., Kim H.J., Chun H.S. Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids. Life Sciences 2007, 80(9):835-841. http://www.ncbi.nlm.nih.gov/pubmed/17166521, 10.1016/j.lfs.2006.11.009.
22. Mirra S.S., Heyman A., McKeel D., et al. The consortium to establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41(4):479-486. http://www.ncbi.nlm.nih.gov/pubmed/2011243, 10.1212/WNL.41.4.479.
23. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 1991, 82(4):239-259. http://www.ncbi.nlm.nih.gov/pubmed/1759558, 10.1007/BF00308809.
24. Kapaki E., Liappas I., Lyras L., et al. Oxidative damage to plasma proteins in patients with chronic alcohol dependence: the effect of smoking. In Vivo 2007, 21(3):523-528. http://www.ncbi.nlm.nih.gov/pubmed/17591364.
25. Lasarzik I., Noppens R.R., Wolf T., et al. Dose-dependent influence of sevoflurane anesthesia on neuronal survival and cognitive outcome after transient forebrain ischemia in Sprague-Dawley rats. Neurocritical Care 2011, 15(3):577-584. http://www.ncbi.nlm.nih.gov/pubmed/21618067, 10.1007/s12028-011-9562-3.
26. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. Journal of Biological Chemistry 1981, 256(4):1604-1607. http://www.ncbi.nlm.nih.gov/pubmed/6257680.
27. Xiao Y., Huang Y., Chen Z.Y. Distribution, depletion and recovery of docosahexaenoic acid are region-specific in rat brain. British Journal of Nutrition 2005, 94(4):544-550. http://www.ncbi.nlm.nih.gov/pubmed/16197579, 10.1079/BJN20051539.
28. Levine R.L. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radical Biology and Medicine 2002, 32(9):790-796. http://www.ncbi.nlm.nih.gov/pubmed/11978480, 10.1016/S0891-5849(02)00765-7.
29. Nyström T. Role of oxidative carbonylation in protein quality control and senescence. EMBO Journal 2005, 24(7):1311-1317. http://www.ncbi.nlm.nih.gov/pubmed/15775985, 10.1038/sj.emboj.7600599.
30. Sircar D., Subbaiah P.V. Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation. Clinical Chemistry 2007, 53(2):251-258. http://www.ncbi.nlm.nih.gov/pubmed/17200134, 10.1373/clinchem.2006.074989.
31. Parker C.E., Graham L.B., Nguyen M.N., et al. An improved GC/MS-based procedure for the quantitation of the isoprostane 15-F2t-IsoP in rat plasma. Molecular Biotechnology 2001, 18(2):105-118. http://www.ncbi.nlm.nih.gov/pubmed/11471453, 10.1385/MB:18:2:105.
32. Janicka M., Kot-Wasik A., Paradziej-Łukowicz J., Sularz-Peszyńska G., Bartoszek A., Namieśnik J. LC-MS/MS determination of isoprostanes in plasma samples collected from mice exposed to doxorubicin or tert-butyl hydroperoxide. International Journal of Molecular Sciences 2013, 14(3):6157-6169. http://www.ncbi.nlm.nih.gov/pubmed/23507752, 10.3390/ijms14036157.
33. Floor E., Wetzel M.G. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. Journal of Neurochemistry 1998, 70(1):268-275. http://www.ncbi.nlm.nih.gov/pubmed/9422371, 10.1046/j.1471-4159.1998.70010268.x.
34. Chandana R., Mythri R.B., Mahadevan A., Shankar S.K., Srinivas Bharath M.M. Biochemical analysis of protein stability in human brain collected at different post-mortem intervals. Indian Journal of Medical Research 2009, 129(2):189-199. http://www.ncbi.nlm.nih.gov/pubmed/19293447.
35. Zhu X., Castellani R.J., Moreira P.I., et al. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radical Biology and Medicine 2012, 52(3):699-704. http://www.ncbi.nlm.nih.gov/pubmed/22137893, 10.1016/j.freeradbiomed.2011.11.004.
36. Kagan V.E., Tyurina Y.Y. Recycling and redox cycling of phenolic antioxidants. Annals of the New York Academy of Sciences 1998, 854:425-434. http://www.ncbi.nlm.nih.gov/pubmed/9928449, 10.1111/j.1749-6632.1998.tb09921.x.
37. Giulivi C., Traaseth N.J., Davies K.J. Tyrosine oxidation products: analysis and biological relevance. Amino Acids 2003, 25(3-4):227-232. http://www.ncbi.nlm.nih.gov/pubmed/14661086, 10.1007/s00726-003-0013-0.
38. Granold M., Moosmann B., Behl C., Hajieva P. Integral membrane proteins are the predominant site of protein oxidation in the aged CNS and in Alzheimer's disease. Free Radical Biology and Medicine 2010, 49:S155. 10.1016/j.freeradbiomed.2010.10.437.
39. Price J.C., Guan S., Burlingame A., Prusiner S.B., Ghaemmaghami S. Analysis of proteome dynamics in the mouse brain. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(32):14508-14513. http://www.ncbi.nlm.nih.gov/pubmed/20699386, 10.1073/pnas.1006551107.
40. Savas J.N., Toyama B.H., Xu T., Yates J.R., Hetzer M.W. Extremely long-lived nuclear pore proteins in the rat brain. Science 2012, 335(6071):942. http://www.ncbi.nlm.nih.gov/pubmed/22300851, 10.1126/science.1217421.
41. Wu H., Williams J., Nathans J. Complete morphologies of basal forebrain cholinergic neurons in the mouse. Elife 2014, 3:e02444. http://www.ncbi.nlm.nih.gov/pubmed/24894464, 10.7554/eLife.02444.
42. Page M.M., Richardson J., Wiens B.E., et al. Antioxidant enzyme activities are not broadly correlated with longevity in 14 vertebrate endotherm species. Age (Dordr) 2010, 32(2):255-270. http://www.ncbi.nlm.nih.gov/pubmed/20431992, 10.1007/s11357-010-9131-2.
43. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiology of Aging 1997, 18(4):351-357. http://www.ncbi.nlm.nih.gov/pubmed/9330961, 10.1016/S0197-4580(97)00056-0.